Difference between revisions of "Team:BostonU/Parts"

Line 213: Line 213:
 
</div></div>
 
</div></div>
 
<div id="panel1" class="link-slideup">
 
<div id="panel1" class="link-slideup">
  <p class="inline-heading-type mainwrap">We submitted two composite parts to the registry: BBa_K2411005 and BBa_K2411008.</p>
+
<p class="inline-heading-type mainwrap">We submitted two composite parts to the registry: BBa_K2411005 and BBa_K2411008.</p>
  <p class="body-type mainwrap">BBa_K2411005: Forward Engineered Toehold 1 with deGFP gene
+
<p class="body-type mainwrap">BBa_K2411005: Forward Engineered Toehold 1 with deGFP gene</p>
This device encodes for a toehold that when activated expresses deGFP. It has an OR2-OR1 promoter, followed by the first forward engineered toehold sequence designed by Green et al. The deGFP follows the toehold, and the device ends with a T7 terminator. The part has been designed for and tested in an E. coli derived transcriptional translation cell free system. In order for the part to function, it needs to be used in conjunction with a trigger RNA. Characterization data can be view on our results page or on the registry.</p>
+
<p class="body-type mainwrap">&nbsp;</p>
 +
<p class="body-type mainwrap">This device encodes for a toehold that when activated expresses deGFP. It has an OR2-OR1 promoter, followed by the first forward engineered toehold sequence designed by Green et al. The deGFP follows the toehold, and the device ends with a T7 terminator. The part has been designed for and tested in an E. coli derived transcriptional translation cell free system. In order for the part to function, it needs to be used in conjunction with a trigger RNA. Characterization data can be view on our results page or on the registry.</p>
 
<p class="body-type mainwrap">&nbsp;</p>
 
<p class="body-type mainwrap">&nbsp;</p>
 
<p class="body-type mainwrap">BBa_K2411008: Forward Engineered Toehold 2 with deGFP gene
 
<p class="body-type mainwrap">BBa_K2411008: Forward Engineered Toehold 2 with deGFP gene
 
This device encodes for a toehold that when activated expresses deGFP. It has an OR2-OR1 promoter, followed by the second best forward engineered toehold sequence designed by Green et al. The deGFP follows the toehold, and the device ends with a T7 terminator. The part has been designed for and tested in an E. coli derived transcriptional translation cell free system. In order for the part to function, it needs to be used in conjunction with a trigger RNA. Characterization data can be view on our results page or on the registry.</p>
 
This device encodes for a toehold that when activated expresses deGFP. It has an OR2-OR1 promoter, followed by the second best forward engineered toehold sequence designed by Green et al. The deGFP follows the toehold, and the device ends with a T7 terminator. The part has been designed for and tested in an E. coli derived transcriptional translation cell free system. In order for the part to function, it needs to be used in conjunction with a trigger RNA. Characterization data can be view on our results page or on the registry.</p>
 
<p class="body-type mainwrap">&nbsp;</p>
 
<p class="body-type mainwrap">&nbsp;</p>
<p class="inline-heading-type mainwrap">In addition to these composite parts, we created registry pages for the OR2-OR1 promoter, the T500 terminator, and both toehold architectures that we used in our composite parts.</p>
+
<p class="body-type mainwrap">In addition to these composite parts, we created registry pages for the OR2-OR1 promoter, the T500 terminator, and both toehold architectures that we used in our composite parts.</p>
 
<p class="body-type mainwrap">&nbsp;</p>
 
<p class="body-type mainwrap">&nbsp;</p>
 
<p class="body-type mainwrap">BBa_K2411000: OR2-OR1 Promoter</p>
 
<p class="body-type mainwrap">BBa_K2411000: OR2-OR1 Promoter</p>

Revision as of 02:02, 31 October 2017

OUR PARTS